Deprecated: Hook elementor/widgets/widgets_registered is deprecated since version 3.5.0! Use elementor/widgets/register instead. in /home/betterhealthcare/public_html/wp-includes/functions.php on line 5758
Outside Insights Archives - CHAIN

CHAIN

How Bennet will help combat ‘superbugs’ in a post-COVID world

Christine MacBrayne

How Bennet will help combat 'superbugs' in a post-COVID world

Christine MacBrayne

Christine MacBrayne

The early days of the COVID-19 pandemic sparked widespread alarm as to how infectious diseases spread. For most of us, COVID-19 was the first pandemic we lived through. Never had a sneeze or a cough from someone within six feet of us felt so dangerous and potentially infectious, or even deadly.

Public health experts and medical professionals like myself have learned a lot since COVID halted our day-to-day lives. The lessons learned are helping America’s infectious disease community identify and address other vulnerabilities in our health care system, leading to a rapidly growing recognition of the next new major threat in the United States healthcare system.

This threat is ‘superbugs.’

Blackstone Plants Its Flag in Boulder, Colorado, an Emerging Biotech Hub

Blackstone

Blackstone Plants Its Flag in Boulder, Colorado, an Emerging Biotech Hub

Blackstone

A unit of real-estate company Blackstone Inc. is acquiring a sprawling life-sciences and office campus in Boulder, Colo., the latest sign that the city at the base of the Rocky Mountains is emerging as a hub for the biotechnology and pharmaceutical industries.

Blackstone’s BioMed Realty Trust Inc., a real-estate owner that focuses on life science and tech buildings, is paying more than $600 million for Flatiron Park, a 22-building complex. BioMed Realty plans to invest another $200 million in the property, in part toward converting traditional office space to labs targeted at new and existing Boulder life-sciences companies.